RIO DE JANEIRO, BRAZIL - The Oxford vaccine trials in Brazil are continuing at a speedy pace. To date, at least 5,000 volunteers have been administered the drug - or a placebo drug - and have not presented any serious adverse . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here